Developing the Next Generation of Targeted, Conditionally Active Cytokine Therapeutics Mar 30, 2023 Blog
Founder & CEO John Mulligan Shares Bonum Therapeutics’ “No Jerks” Approach to Hiring Feb 14, 2023 Blog
GeekWire Seattle biotech startup born out of a Roche buyout lands $93M to advance therapies Nov 15, 2022 Media
BioPharmaDive After $250M Roche buyout, a startup plans a second strike with fresh funding Nov 15, 2022 Media